Basilar Invagination Clinical Trial
Official title:
A Prospective Study of Natural History and Clinical Outcomes for Basilar Invagination
Verified date | April 2023 |
Source | Xuanwu Hospital, Beijing |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
A Prospective Study of Natural History and Clinical Outcomes for Basilar Invagination
Status | Enrolling by invitation |
Enrollment | 200 |
Est. completion date | June 30, 2024 |
Est. primary completion date | December 1, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: 1. BI discovered by the patient not incidentally; 2. Patients with depression of the skull base caused by congenital skeletal developmental malformations and symptoms; 3. The patient was initially treated in our center, and the interval between onset and treatment was at least 1 month or no treatment; 4. The imaging diagnosis of BI meets the standard (3-5mm higher than the Chamberlain's line) Exclusion Criteria: 1. secondary BI caused by trauma, pathological factors such as rheumatoid arthritis, hyperparathyroidism, osteogenesis imperfecta, rickets, osteomalacia, spinal cord tumors, tuberculosis, inflammation of adjacent structures, and simple AAD, odontoid body deformity, etc. 2. spinal vascular disease, intervertebral disc herniation, tethered spinal cord disease and other diseases that may cause symptoms. 3. Patients with incomplete imaging data or symptomatic data. |
Country | Name | City | State |
---|---|---|---|
China | Xuanwu Hospital, Capital Medical University | Beijing |
Lead Sponsor | Collaborator |
---|---|
Xuanwu Hospital, Beijing |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | improved symptoms | The symptoms improved after the opration or natural condition.(JOA scores and SF-12 scores) | 1 months postoperatively | |
Primary | improved symptoms | The symptoms improved after the opration or natural condition.(JOA scores and SF-12 scores) | 3 months postoperatively | |
Primary | improved symptoms | The symptoms improved after the opration or natural condition.(JOA scores and SF-12 scores) | 6 months postoperatively | |
Primary | improved radiology | improved ADI, CCA, CTA ; The basilar invagination reduced | 1 months postoperatively | |
Primary | improved radiology | improved ADI, CCA, CTA ; The basilar invagination reduced | 3 months postoperatively | |
Primary | improved radiology | improved ADI, CCA, CTA ; The basilar invagination reduced | 6 months postoperatively | |
Primary | operation complication | operation complication(Excessive bleeding, bronchopneumonia, vertebral artery injury ) | 1 months postoperatively | |
Primary | operation complication | operation complication(Excessive bleeding, bronchopneumonia, vertebral artery injury ) | 3 months postoperatively | |
Primary | operation complication | operation complication(Excessive bleeding, bronchopneumonia, vertebral artery injury ) | 6 months postoperatively |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05754554 -
Clinical Study of the Treatment of Chiari Malformation Combined With Type II Skull Base Depression
|
N/A | |
Recruiting |
NCT05849363 -
A Prospective Study of Surgical Treatment Strategies for Goal B Type Basilar Invagination
|
N/A | |
Completed |
NCT04220541 -
Investigation of the Effects of Exercise on Patients With Chiari Malformation
|
N/A |